Literature DB >> 25001952

Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism affects sympathetic tone in a gender-specific way.

Chuan-Chia Chang1, Hsin-An Chang2, Tien-Yu Chen2, Wen-Hui Fang3, San-Yuan Huang4.   

Abstract

The Val/Val genotype of the brain-derived neurotrophic factor (BDNF) polymorphism (Val66Met) has been reported to affect human anxiety-related phenotypes. Substantial research has demonstrated that anxiety is associated with sympathetic activation, while sex steroid hormones have been shown to exert differential actions in regulating BDNF expression. Thus, we examined whether the BDNF variant modulates autonomic function in a gender-dependent manner. From 708 adults initially screened for medical and psychiatric illnesses, a final cohort of 583 drug-free healthy Han Chinese (355 males, 228 females; age 34.43±8.42 years) was recruited for BDNF genotyping (Val/Val: 136, 23.3%, Val/Met: 294, 50.4%, and Met/Met: 153, 26.2%). Time- and frequency-domain analyses of heart rate variability (HRV) were used to assess autonomic outflow to the heart. Significant genotype-by-gender interaction effects were found on HRV indices. Even after adjusting for possible confounders, male participants bearing the Val/Val genotype had significant increases in low frequency (LF), LF% and LF/high frequency (HF) ratio, indicating altered sympathovagal balance with increased sympathetic modulation, compared to male Met/Met homozygotes. Females, however, showed an opposite but non-significant pattern. These results suggest that the studied BDNF polymorphism is associated with sympathetic control in a gender-specific way. The findings here support the view that male subjects with the Val/Val genotype have increased risk of anxiety by association with sympathetic activation.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autonomic nervous system (ANS); Brain-derived neurotrophic factor (BDNF); Heart rate variability (HRV); Polymorphism; Sympathetic control

Mesh:

Substances:

Year:  2014        PMID: 25001952     DOI: 10.1016/j.psyneuen.2014.04.019

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  6 in total

Review 1.  Brain-derived neurotrophic factor rs6265 (Val66Met) single nucleotide polymorphism as a master modifier of human pathophysiology.

Authors:  Van Thuan Nguyen; Braxton Hill; Naiya Sims; Aaron Heck; Marcus Negron; Claire Lusk; Cristi L Galindo
Journal:  Neural Regen Res       Date:  2023-01       Impact factor: 6.058

2.  Functional Ser205Leu polymorphism of the nerve growth factor receptor (NGFR) gene is associated with vagal autonomic dysregulation in humans.

Authors:  Chuan-Chia Chang; Wen-Hui Fang; Hsin-An Chang; San-Yuan Huang
Journal:  Sci Rep       Date:  2015-08-17       Impact factor: 4.379

3.  Linking an Anxiety-Related Personality Trait to Cardiac Autonomic Regulation in Well-Defined Healthy Adults: Harm Avoidance and Resting Heart Rate Variability.

Authors:  Lien-Cheng Kao; Yu-Wen Liu; Nian-Sheng Tzeng; Terry B J Kuo; San-Yuan Huang; Chuan-Chia Chang; Hsin-An Chang
Journal:  Psychiatry Investig       Date:  2016-07-25       Impact factor: 2.505

4.  Correlation between health-related quality of life in the physical domain and heart rate variability in asymptomatic adults.

Authors:  Wan-Chun Lu; Nian-Sheng Tzeng; Yu-Chen Kao; Chin-Bin Yeh; Terry B J Kuo; Chuan-Chia Chang; Hsin-An Chang
Journal:  Health Qual Life Outcomes       Date:  2016-10-21       Impact factor: 3.186

5.  Association of neuropeptide Y promoter polymorphism (rs16147) with perceived stress and cardiac vagal outflow in humans.

Authors:  Hsin-An Chang; Wen-Hui Fang; Tieh-Ching Chang; San-Yuan Huang; Chuan-Chia Chang
Journal:  Sci Rep       Date:  2016-08-16       Impact factor: 4.379

Review 6.  Critical Issues in BDNF Val66Met Genetic Studies of Neuropsychiatric Disorders.

Authors:  Shih-Jen Tsai
Journal:  Front Mol Neurosci       Date:  2018-05-15       Impact factor: 5.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.